Reinhard Hohlfeld Selected Research

Reinhard Hohlfeld Research Topics

Disease

88	Multiple Sclerosis 04/2022 - 01/2002
10	Relapsing-Remitting Multiple Sclerosis 01/2018 - 09/2007
8	Progressive Multifocal Leukoencephalopathy 01/2019 - 11/2005
6	Inflammation (Inflammations) 01/2021 - 06/2004
6	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 11/2008
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 03/2003
6	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 11/2005
5	Neuromyelitis Optica (Devic's Disease) 01/2018 - 04/2007
5	Polymyositis 06/2012 - 07/2002
4	Neoplasms (Cancer) 01/2021 - 05/2009
4	Central Nervous System Diseases (CNS Diseases) 12/2017 - 08/2004
4	Myositis (Idiopathic Inflammatory Myopathies) 03/2016 - 05/2003
4	Necrosis 06/2004 - 01/2002
3	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2018
3	Autoimmune Diseases of the Nervous System 01/2021 - 01/2010
3	Neuroinflammatory Diseases 07/2019 - 10/2014
3	Encephalomyelitis (Myeloencephalitis) 01/2018 - 08/2004
3	Infections 12/2016 - 08/2005
3	Inclusion Body Myositis 06/2012 - 09/2003
3	Rhabdomyosarcoma 05/2003 - 07/2002
2	Optic Neuritis (Retrobulbar Neuritis) 07/2019 - 04/2008
2	Atrophy 01/2019 - 09/2015
2	Disease Progression 01/2019 - 10/2007
2	Melanoma (Melanoma, Malignant) 08/2016 - 02/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2015 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011 - 03/2003
2	Thymoma (Thymic Carcinoma) 09/2008 - 07/2008
2	Transverse Myelitis (Necrotizing Myelitis) 04/2008 - 04/2007
1	Fatigue 01/2021
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2020
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Ganglion Cysts (Ganglion) 07/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Multiple Myeloma 01/2017
1	Leukopenia 12/2016
1	Thyroid Diseases (Thyroid Disease) 12/2016

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 12/2016 - 01/2002
15	AntibodiesIBA 01/2021 - 04/2007
12	AutoantibodiesIBA 01/2021 - 11/2008
11	Natalizumab (Tysabri)FDA Link 01/2016 - 11/2005
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2002
10	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 02/2010
10	Glatiramer Acetate (Copaxone)FDA Link 05/2014 - 11/2002
8	Myelin-Oligodendrocyte GlycoproteinIBA 07/2019 - 05/2009
8	Immunoglobulin G (IgG)IBA 07/2019 - 08/2005
7	Oligoclonal BandsIBA 12/2016 - 06/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
5	Monoclonal AntibodiesIBA 01/2019 - 01/2002
5	EnzymesIBA 10/2014 - 11/2002
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2006
4	Peptides (Polypeptides)IBA 01/2019 - 01/2002
4	Sphingosine-1-Phosphate ReceptorsIBA 09/2015 - 02/2011
4	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 08/2005
3	Pharmaceutical PreparationsIBA 12/2016 - 11/2005
3	Alemtuzumab (Campath)FDA Link 12/2016 - 11/2012
3	Neuroprotective AgentsIBA 09/2015 - 01/2002
3	N-acetyltalosaminuronic acid (NAT)IBA 11/2014 - 09/2011
3	MicroRNAs (MicroRNA)IBA 09/2012 - 12/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004 - 01/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2003 - 01/2002
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2020
2	InterferonsIBA 01/2019 - 05/2014
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 01/2002
2	ocrelizumabIBA 01/2018 - 01/2017
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2017 - 06/2015
2	LigandsIBA 01/2015 - 01/2002
2	Aquaporin 4IBA 07/2011 - 04/2007
2	Cladribine FDA LinkGeneric 07/2011 - 01/2002
2	CytokinesIBA 05/2011 - 01/2002
2	ProteomeIBA 04/2011 - 06/2008
2	Nerve Growth Factors (Neurotrophins)IBA 02/2008 - 04/2006
2	Complement System Proteins (Complement)IBA 10/2007 - 09/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2007 - 01/2002
1	AutoantigensIBA 04/2022
1	BNT162 VaccineIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	ponesimodIBA 01/2021
1	teriflunomideIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 07/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	Myelin Basic ProteinIBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Daclizumab (Zenapax)FDA Link 12/2016
1	Transaminases (Aminotransferases)IBA 12/2016
1	IpilimumabIBA 08/2016
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2015

Therapy/Procedure

31	Therapeutics 01/2022 - 01/2002
3	Lasers (Laser) 09/2011 - 04/2003
2	Immunotherapy 12/2017 - 10/2004
2	Plasma Exchange 12/2012 - 11/2012